The invention revolution has always been inspired by technology from fiction — how do we pluck a device out of TV science fiction and make it real? Back in 2012, the Qualcomm Foundation and the XPRIZE Foundation worked together to develop the Qualcomm Tricorder XPRIZE, a Star Trek-inspired competition that set out to provide anyone with the ability to diagnose health conditions by using a real-world version of the Tricorder.
After five years (the same duration as Starship Enterprise’s original mission) of competition, we’re excited to announce that Final Frontier Medical Devices takes the top prize.
The Blue Cross Blue Shield Association (BCBSA) today released the second edition of a Moody’s Analytics report that finds a direct link between a population’s health and a growing economy, higher incomes and lower unemployment.
The CVS Health Foundation today announced more than $1 million in grants to 33 Free and Charitable Clinics as part of a multi-year grant program with the National Association of Free & Charitable Clinics (NAFC). Over the past four years, the Foundation has donated nearly $5 million to NAFC to increase access to quality care and support the management of chronic disease.
It’s a critical time for the arts and healthcare across the USA. In solidarity with Americans for the Arts, the National Endowment for the Arts, and dozens of arts organizations, the AATA was a proud National Partner for the 30th annual Arts Advocacy Day, March 20 and 21, 2017, in Washington, DC.
Glovax Biotech Corp., an integrated distributor and retailer of vaccines in the Philippines, has joined Business Call to Action (BCtA) with a commitment to provide 40 million vaccine doses to the country’s medium- and low-income communities by 2020, reducing the cost of vaccinations by 75 percent and preventing countless disease outbreaks.
San Francisco resident Mounir Ebdellaoi has depended on his glasses to see since age 14. Ebdellaoi lives in one of the city’s most distressed neighborhoods and was recently mugged and his eyewear was destroyed in the altercation.
GSK has today announced a new partnership with the London School of Hygiene & Tropical Medicine to establish the Sir Andrew Witty GSK Scholarships. The partnership recognises the contribution Sir Andrew has made to the company and more broadly, his deep commitment to addressing health challenges in the developing world, particularly in Africa.
It can take longer to diagnose rare diseases than many common diseases. On average, rare disease diagnosis takes 7.6 years in the U.S. and 5.6 years in the UK. Rare diseases such as the primary immunodeficiency (PI) disorders Gaucher disease, Fabry disease, and Hunter syndrome can be devastating, as they are difficult to detect and equally difficult to treat.
After more than six decades of fighting the spread of trachoma in Morocco, on November 14, 2016, the World Health Organization (WHO) acknowledged that the Moroccan government eliminated the world’s leading infectious cause of blindness as a public health problem.
At kate spade new york and its Foundation, we believe that a woman’s mental health is foundational to her achieving sustainable long-term empowerment...
This category covers areas that aren't our signature charities. Main topics can include Homes For Our Troops as well as smaller charity organizations...
Corporate governance, risk management, operational integrity, and regulatory compliance are demanding challenges that companies face in today’s ever...
Cascale shares insights regarding policy and regulation impacting the consumer goods industry, and highlights how it's supporting members prepare for...
Cascale organizes and participates in a series of events, leveraging its position as a global convener of close to half the sector to bring together...
In states where Key has a presence, there are approximately 1.7 million low- to moderate-income (LMI) households. Many LMI individuals don’t have bank...
Entergy’s 2024 performance report, “Energy for a better future” presents an overview of our company’s 2024 achievements, future plans and strategies...
